|Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas|
FF Casanueva, ME Molitch, JA Schlechte, R Abs, V Bonert, MD Bronstein, ...
Clinical endocrinology 65 (2), 265-273, 2006
|A consensus on criteria for cure of acromegaly|
A Giustina, P Chanson, MD Bronstein, A Klibanski, S Lamberts, ...
The Journal of Clinical Endocrinology & Metabolism 95 (7), 3141-3148, 2010
|Pituitary tumor transforming gene (PTTG) expression in pituitary adenomas|
X Zhang, GA Horwitz, AP Heaney, M Nakashima, TR Prezant, ...
The Journal of Clinical Endocrinology & Metabolism 84 (2), 761-767, 1999
|Structure, expression, and function of human pituitary tumor-transforming gene (PTTG)|
X Zhang, GA Horwitz, TR Prezant, A Valentini, M Nakashima, ...
Molecular Endocrinology 13 (1), 156-166, 1999
|The theory of constructed emotion: an active inference account of interoception and categorization|
Social cognitive and affective neuroscience 12 (1), 1-23, 2017
|Expert consensus document: a consensus on the medical treatment of acromegaly|
A Giustina, P Chanson, D Kleinberg, MD Bronstein, DR Clemmons, ...
Nature Reviews Endocrinology 10 (4), 243-248, 2014
|A consensus on the diagnosis and treatment of acromegaly complications|
S Melmed, FF Casanueva, A Klibanski, MD Bronstein, P Chanson, ...
Pituitary 16 (3), 294-302, 2013
|Pasireotide versus octreotide in acromegaly: a head-to-head superiority study|
A Colao, MD Bronstein, P Freda, F Gu, CC Shen, M Gadelha, M Fleseriu, ...
The Journal of Clinical Endocrinology & Metabolism 99 (3), 791-799, 2014
|Pasireotide versus continued treatment with octreotide or lanreotide in patients with inadequately controlled acromegaly (PAOLA): a randomised, phase 3 trial|
MR Gadelha, MD Bronstein, T Brue, M Coculescu, M Fleseriu, ...
The lancet Diabetes & endocrinology 2 (11), 875-884, 2014
|Long-term follow-up of prolactinomas: normoprolactinemia after bromocriptine withdrawal|
VQ Passos, JJS Souza, NRC Musolino, MD Bronstein
The Journal of Clinical Endocrinology & Metabolism 87 (8), 3578-3582, 2002
|Diagnosis and management of hyperprolactinemia: results of a Brazilian multicenter study with 1234 patients|
L Vilar, MC Freitas, LA Naves, LA Casulari, M Azevedo, R Montenegro, ...
Journal of endocrinological investigation 31 (5), 436-444, 2008
|Prolactinomas and pregnancy|
Pituitary 8 (1), 31-38, 2005
|Optical coherence tomography analysis of axonal loss in band atrophy of the optic nerve|
MLR Monteiro, BC Leal, AAM Rosa, MD Bronstein
British journal of ophthalmology 88 (7), 896-899, 2004
|Human macroprolactin displays low biological activity via its homologous receptor in a new sensitive bioassay|
A Glezer, CRJ Soares, JG Vieira, D Giannella-Neto, MTCP Ribela, ...
The Journal of Clinical Endocrinology & Metabolism 91 (3), 1048-1055, 2006
|Treatment of acromegaly with octreotide‐LAR: extensive experience in a Brazilian institution|
RS Jallad, NRC Musolino, LR Salgado, MD Bronstein
Clinical endocrinology 63 (2), 168-175, 2005
|Current management practices for acromegaly: an international survey|
A Giustina, MD Bronstein, FF Casanueva, P Chanson, E Ghigo, KKY Ho, ...
Pituitary 14 (2), 125-133, 2011
|Medical management of pituitary adenomas: the special case of management of the pregnant woman|
MD Bronstein, LR Salgado, NR de Castro Musolino
Pituitary 5 (2), 99-107, 2002
|A consensus statement on acromegaly therapeutic outcomes|
S Melmed, MD Bronstein, P Chanson, A Klibanski, FF Casanueva, ...
Nature Reviews Endocrinology 14 (9), 552-561, 2018
|Safety and efficacy of oral octreotide in acromegaly: results of a multicenter phase III trial|
S Melmed, V Popovic, M Bidlingmaier, M Mercado, AJ Van Der Lely, ...
The Journal of Clinical Endocrinology & Metabolism 100 (4), 1699-1708, 2015
|Challenges in the diagnosis and management of acromegaly: a focus on comorbidities|
A Abreu, AP Tovar, R Castellanos, A Valenzuela, CMG Giraldo, ...
Pituitary 19 (4), 448-457, 2016